mhurhangee/ep-ind-claims huggingface dataset:
A method for predicting a pregnant subject's risk of acquiring a pregnancy-related vascular disorder, comprising: (a) (i) measuring N-terminal pro-C-type natriuretic peptide (NTproCNP) in a biological sample from the pregnant subject, and (ii) comparing the measured level of NTproCNP against a reference interval from a suitable control population of pregnant subjects; wherein an increase in the measured circulating level of NTproCNP compared with the reference interval from the control population is predictive of acquiring a pregnancy-related vascular disorder, and further wherein said measuring step comprises detecting binding between NTproCNP and a binding agent that selectively binds to NTproCNP; or (b) (i) measuring NTproCNP in a biological sample from the pregnant subject at a first time point, and (ii) measuring NTproCNP in a biological sample from the same subject at a second time point; wherein an increase in the circulating level of NTproCNP between the first and second time points is predictive of acquiring a pregnancy-related vascular disorder, and further wherein said measuring step comprises detecting binding between NTproCNP and a binding agent that selectively binds to NTproCNP. (a) (i) measuring N-terminal pro-C-type natriuretic peptide (NTproCNP) in a biological sample from the pregnant subject, and (ii) comparing the measured level of NTproCNP against a reference interval from a suitable control population of pregnant subjects; wherein an increase in the measured circulating level of NTproCNP compared with the reference interval from the control population is predictive of acquiring a pregnancy-related vascular disorder, and further wherein said measuring step comprises detecting binding between NTproCNP and a binding agent that selectively binds to NTproCNP; or (i) measuring N-terminal pro-C-type natriuretic peptide (NTproCNP) in a biological sample from the pregnant subject, and (ii) comparing the measured level of NTproCNP against a reference interval from a suitable control population of pregnant subjects; (b) (i) measuring NTproCNP in a biological sample from the pregnant subject at a first time point, and (ii) measuring NTproCNP in a biological sample from the same subject at a second time point; wherein an increase in the circulating level of NTproCNP between the first and second time points is predictive of acquiring a pregnancy-related vascular disorder, and further wherein said measuring step comprises detecting binding between NTproCNP and a binding agent that selectively binds to NTproCNP. (i) measuring NTproCNP in a biological sample from the pregnant subject at a first time point, and (ii) measuring NTproCNP in a biological sample from the same subject at a second time point;
Electromagnetic actuator for an electric contactor, the actuator comprising: - a magnetic core having first and second stop surfaces (422A, 422B), two lateral branches (42A, 42B), each lateral branch having a first end (420A, 420B) and a second end (421A, 421B), the first ends being connected together by a central branch, - an electromagnetic coil which is wound around the central branch of the core and is capable of generating a magnetic flux, called the coil flux, through the core, - a magnetised member having a permanent magnet and at least one metal part, the magnetised member being capable of generating a magnetic flux, called the magnet flux, and having first and second contact surfaces (802A, 802B), the magnetised member being movable relative to the core between a first position in which the first contact surface is in abutment against the first stop surface and a second position in which the second contact surface is in abutment against the second stop surface, the space between the first contact surface and the first stop surface forming a first air gap and the space between the second contact surface and the second stop surface forming a second air gap, the magnetised member being configured to be in one of the first and second positions in the absence of a coil flux, the magnetised member, outside the contact surfaces (802A, 802B) and the stop surfaces (422A, 422B), being separated from each lateral branch (42A, 42B) by a respective lateral gap (34A, 34B), each lateral gap being capable of deflecting the magnet flux and the coil flux towards a corresponding air gap (E1, E2), characterised in that each air gap (E1, E2) has an air-gap reluctance (R32A, R32B), each lateral gap (34A, 34B) has a gap reluctance (R34A, R34B), each air-gap reluctance being less than or equal to half the corresponding gap reluctance. - a magnetic core having first and second stop surfaces (422A, 422B), two lateral branches (42A, 42B), each lateral branch having a first end (420A, 420B) and a second end (421A, 421B), the first ends being connected together by a central branch, - an electromagnetic coil which is wound around the central branch of the core and is capable of generating a magnetic flux, called the coil flux, through the core, - a magnetised member having a permanent magnet and at least one metal part, the magnetised member being capable of generating a magnetic flux, called the magnet flux, and having first and second contact surfaces (802A, 802B), the magnetised member being movable relative to the core between a first position in which the first contact surface is in abutment against the first stop surface and a second position in which the second contact surface is in abutment against the second stop surface, the space between the first contact surface and the first stop surface forming a first air gap and the space between the second contact surface and the second stop surface forming a second air gap, the magnetised member being configured to be in one of the first and second positions in the absence of a coil flux,
Combination of an LED module with an integrated emergency light function and at least one operating device, wherein the LED module comprises a plurality of LEDs mounted on a common carrier, wherein the LED module is configured to connect to the at least one operating device (11, 12) and the plurality of LEDs are configured to be activated in a controlled manner by the at least one operating device (11, 12), wherein the LED module (20; 51, 53) is configured such that in a normal operating mode, a group of LEDs from the plurality of LEDs can be activated by the at least one operating device (11, 12), in order to effect a light output via a first light-emitting surface of the LED module (20; 51, 53), in an emergency light operating mode, at least a part of the LEDs belonging to the group can be activated by the at least one operating device (11, 12), in order to effect a light output via a second light-emitting surface of the LED module (20; 51, 53), wherein when the emergency light operating mode is initiated, a further part (34, 35) of the LEDs belonging to the group is not supplied with power, so that the second light-emitting surface has a first dimension in a first direction and in a second direction perpendicular thereto has a second dimension that is smaller than the first dimension, and wherein the first light-emitting surface and the second light-emitting surface have different shapes, wherein the first light-emitting surface has a third dimension in the first direction and in the second direction has a fourth dimension that is greater than the second dimension of the second light-emitting surface, characterized in that the LED module (20; 51, 53) is configured such that a further group of LEDs (36, 37) of the plurality of LEDs can be selectively activated by the at least one operating device (11, 12) only in the emergency light operating mode, in order to effect a light output via the second light-emitting surface of the LED module (20; 51, 53), wherein the third dimension of the first light-emitting surface is smaller than the first dimension of the second light-emitting surface.
A common control channel resource allocation method of a base station in a long term evolution, LTE, communication system, comprising: determining a carrier type; if a carrier is a non-backward compatible carrier based on a result of the determination, allocating resources for a dedicated reference signal, DRS,-based common control channel based on a parameter of a backward compatible carrier; or if the carrier is a backward compatible carrier based on a result of the determination, allocating resources for a physical control format indicator channel, PCFICH,, allocating resources for a physical hybrid automatic repeat request indicator channel, PHICH, and allocating resources for the DRS-based common control channel at a location determined based on an index of a physical resource block, PRB, to which the PCFICH is mapped. determining a carrier type; if a carrier is a non-backward compatible carrier based on a result of the determination, allocating resources for a dedicated reference signal, DRS,-based common control channel based on a parameter of a backward compatible carrier; or if the carrier is a backward compatible carrier based on a result of the determination, allocating resources for a physical control format indicator channel, PCFICH,, allocating resources for a physical hybrid automatic repeat request indicator channel, PHICH, and allocating resources for the DRS-based common control channel at a location determined based on an index of a physical resource block, PRB, to which the PCFICH is mapped.
An electrolytic device comprising a housing including at least first and second adjacent liquid flow-through channels, each channel having first ends (20a, 22a) and second ends (20b, 22b), an inlet (24, 28) adjacent the upstream end of each channel and an outlet (26, 30) adjacent the downstream end of each channel, said first ends (20a, 22a) being adjacent to each other and said second ends (20b, 22b) being adjacent to each other; a first barrier impermeable to ion flow and to bulk liquid flow disposed between said first and second channels; a first electrode assembly disposed adjacent to both of said first ends (20a, 22a) in electrical communication with said first and second channels (20, 22); a second electrode assembly disposed adjacent to both of said second ends (20b, 22b) in electrical communication with said first and second channels; a first ion exchange barrier assembly which permits ion transport and blocks bulk liquid flow disposed adjacent both of said first ends (20a, 22a) between said first electrode assembly and said first ends (20a, 22a); and a second ion exchange barrier assembly which permits ion transport and blocks bulk liquid flow disposed adjacent said second ends (20b, 22b) between said second electrode assembly and both of said second ends (20b, 22b).
A medicament injector comprising: a reusable, user-powered automatic injection assembly including a medicament injection subassembly; and a medicament module removably insertable into said reusable, user-powered automatic injection assembly; said medicament injection subassembly including a sealing element (162, 164, 166) and a sealing element seating assembly which provides damping of forward motion of said medicament injection subassembly along a longitudinal axis which is greater than damping of rearward motion of said medicament injection subassembly along said longitudinal axis, characterized in that said sealing element seating assembly includes a seating area at a rearward end thereof, said seating area includes a planar surface and a tapered surface. a reusable, user-powered automatic injection assembly including a medicament injection subassembly; and a medicament module removably insertable into said reusable, user-powered automatic injection assembly; said medicament injection subassembly including a sealing element (162, 164, 166) and a sealing element seating assembly which provides damping of forward motion of said medicament injection subassembly along a longitudinal axis which is greater than damping of rearward motion of said medicament injection subassembly along said longitudinal axis, characterized in that said sealing element seating assembly includes a seating area at a rearward end thereof, said seating area includes a planar surface and a tapered surface.
A lidded vessel made of plastic for laboratory use, comprising • a tubular vessel having a vessel base at the bottom, a vessel opening at the top and a sealing area on the inner wall below the vessel opening, • a lid which has a lid base and a plug which protrudes from the inner side of the lid base and can be inserted through the vessel opening into a sealing position, in which the plug sealingly bears against the sealing area, • wherein the lid engages with the plug in the vessel opening in a parking position, without sealingly bearing against the sealing area, and • a first latching apparatus for releasably latching the lid to the vessel in the parking position is provided, characterized in that the first latching apparatus has a radially inwardly projecting first latching projection on the inner wall of the vessel and the first latching apparatus has a radially outwardly projecting second latching projection on the outer side of the plug and a bead (14.2) circumscribes the outer side of the plug, which bead has the function of the second latching projection and latches to the first latching projection in the parking position. • a tubular vessel having a vessel base at the bottom, a vessel opening at the top and a sealing area on the inner wall below the vessel opening, • a lid which has a lid base and a plug which protrudes from the inner side of the lid base and can be inserted through the vessel opening into a sealing position, in which the plug sealingly bears against the sealing area, • wherein the lid engages with the plug in the vessel opening in a parking position, without sealingly bearing against the sealing area, and • a first latching apparatus for releasably latching the lid to the vessel in the parking position is provided,
An insertion instrument for inserting an implant comprising: a base including two slideable arms; two opposed ramps having an initial angle between the respective longitudinal axes thereof, each ramp having a proximal and a distal end; and two distraction guides disposed between the opposed ramps, the distraction guides movable with respect to the opposed ramps along longitudinal axes thereof, the distraction guides coupled to the slidable arms to follow lateral motions of the slidable arms, wherein the distraction guides comprise longitudinal edges interfacing with respective longitudinal edges of the opposed ramps, and wherein the longitudinal edges of the distraction guide are oriented at a lordotic angle to one another such that translation of the distraction guides distally along longitudinal axes of the opposed ramps separates the opposed ramps while holding the initial angle between the opposed ramps constant; wherein angled surfaces along the longitudinal edges of the distraction guides and angled surfaces along the longitudinal edges of the opposed ramps cooperate such that the lateral motion of the distraction guides enables the opposed ramps to approach one another in response to a compressive force acting upon the opposed ramps. a base including two slideable arms; two opposed ramps having an initial angle between the respective longitudinal axes thereof, each ramp having a proximal and a distal end; and two distraction guides disposed between the opposed ramps, the distraction guides movable with respect to the opposed ramps along longitudinal axes thereof, the distraction guides coupled to the slidable arms to follow lateral motions of the slidable arms,
A compound according to Formula: wherein: Q is phenylene or pyridylene, each of which is optionally substituted with one or two substituents selected from halogen, methyl, -CH 2 F, -CHF 2, or -CF 3; Z is: L is selected from the group consisting of a bond, C 1-3 -alkylene, and C 1-3 -alkylene-O-; Y' is phenyl or pyridyl, wherein said phenyl and pyridyl are substituted with one, two, or three groups selected from halogen, C 1-3 -alkyl, fluoro-C 1-3 -alkyl, C 1-3 -alkoxy, and fluoro-C 1-3 -alkoxy; R 1 is C 1-4 -alkyl or C 3-6 -cycloalkyl, wherein: said C 1-4 -alkyl is optionally substituted with 1 to 3 substituents independently selected from fluoro, hydroxyl, C 1-3 -alkoxy, and fluoro-C 1-3 -alkoxy; and said C 3-6 -cycloalkyl is optionally substituted with 1 to 3 substituents independently selected from fluoro, hydroxyl, C 1-3 -alkyl, fluoro-C 1-3 -alkyl, C 1-3 -alkoxy, and fluoro-C 1-3 -alkoxy; R 2 is hydrogen, fluoro, CH 3, -CH 2 F, -CHF 2, or CF 3; R 3 is halogen, C 1-4 -alkyl, halo-C 1-4 -alkyl, C 1-4 -alkoxy, or halo-C 1-4 -alkoxy; R 4 is hydroxyl, C 1-6 -alkoxy, halo-C 1-6 -alkoxy, or -NR 5 R 6; R 5 is hydrogen, C 1-6 -alkyl, or halo-C 1-6 -alkyl; R 6 is hydrogen or C 1-6 -alkyl, wherein said C 1-6 -alkyl is optionally substituted with 1 to 6 substituents independently selected from halogen, -SO 3 H, and -CO 2 H; and n is 0 or 1; or a pharmaceutically acceptable salt, a stereoisomer, a mixture of stereoisomers, or a tautomer thereof. Q is phenylene or pyridylene, each of which is optionally substituted with one or two substituents selected from halogen, methyl, -CH 2 F, -CHF 2, or -CF 3; Z is: L is selected from the group consisting of a bond, C 1-3 -alkylene, and C 1-3 -alkylene-O-; Y' is phenyl or pyridyl, wherein said phenyl and pyridyl are substituted with one, two, or three groups selected from halogen, C 1-3 -alkyl, fluoro-C 1-3 -alkyl, C 1-3 -alkoxy, and fluoro-C 1-3 -alkoxy; R 1 is C 1-4 -alkyl or C 3-6 -cycloalkyl, wherein: said C 1-4 -alkyl is optionally substituted with 1 to 3 substituents independently selected from fluoro, hydroxyl, C 1-3 -alkoxy, and fluoro-C 1-3 -alkoxy; and said C 3-6 -cycloalkyl is optionally substituted with 1 to 3 substituents independently selected from fluoro, hydroxyl, C 1-3 -alkyl, fluoro-C 1-3 -alkyl, C 1-3 -alkoxy, and fluoro-C 1-3 -alkoxy; said C 1-4 -alkyl is optionally substituted with 1 to 3 substituents independently selected from fluoro, hydroxyl, C 1-3 -alkoxy, and fluoro-C 1-3 -alkoxy; and said C 3-6 -cycloalkyl is optionally substituted with 1 to 3 substituents independently selected from fluoro, hydroxyl, C 1-3 -alkyl, fluoro-C 1-3 -alkyl, C 1-3 -alkoxy, and fluoro-C 1-3 -alkoxy; R 2 is hydrogen, fluoro, CH 3, -CH 2 F, -CHF 2, or CF 3; R 3 is halogen, C 1-4 -alkyl, halo-C 1-4 -alkyl, C 1-4 -alkoxy, or halo-C 1-4 -alkoxy; R 4 is hydroxyl, C 1-6 -alkoxy, halo-C 1-6 -alkoxy, or -NR 5 R 6; R 5 is hydrogen, C 1-6 -alkyl, or halo-C 1-6 -alkyl; R 6 is hydrogen or C 1-6 -alkyl, wherein said C 1-6 -alkyl is optionally substituted with 1 to 6 substituents independently selected from halogen, -SO 3 H, and -CO 2 H; and n is 0 or 1;
Body panel for a transport vehicle comprising a heat exchange device, said body panel having a smaller dimension, named the thickness, extending in a first direction, named the radial direction, and two larger dimensions extending in two directions perpendicular to one another and perpendicular to the radial direction, said panel comprising a supporting plate having a first main face, named the inner face, intended to be in contact with an internal space of the transport vehicle and a second face, named the outer face, opposite said inner face; the heat exchange device is fastened to the supporting plate by a fastening device and extends on said outer face of the supporting plate and so as to extend in contact with an external environment of the transport vehicle, said heat exchange device being shaped to allow a circulation of a heat transfer fluid in a heat transfer fluid circuit between at least one heat transfer fluid inlet of the heat exchange device and at least one heat transfer fluid outlet of the heat exchange device and to allow a dissipation of heat of the heat transfer fluid to the external environment of the transport vehicle; characterised in that the supporting plate forms, on its outer face, an indentation extending in the thickness of the supporting plate, said indentation being adapted to receive the heat exchange device and so that the heat exchange device does not extend beyond the general profile of the body of the transport vehicle.
A method for preparing samples to test for an analyte of interest, the method comprising: providing a liquid composition (14, 114) comprising a source (12, 112) and a diluent (13, 113); providing a sample preparation system (100, 300) comprising a deformable freestanding liner, and a freestanding container that is more rigid than the deformable liner, and a lid (106, 306); positioning the liquid composition (14, 114) in a reservoir defined by the deformable freestanding liner; coupling the lid (106, 306) to the deformable freestanding liner; positioning the deformable liner within a second reservoir defined by the freestanding container; filtering the liquid composition (14, 114) to form a filtrate (16, 116) comprising the analyte of interest, if present, with the proviso that the filtering step is unnecessary, if the source (12, 112) is completely dissolved in the diluent (13, 113), such that the liquid composition (14, 114) includes a minimal amount of insoluble matter; removing at least a portion of the filtrate (16, 116) or unfiltered liquid composition (14, 114) from the sample preparation system (100, 300) to form a sample by applying pressure to the deformable freestanding liner by hand or by an additional device, via an aperture formed in the base of the free standing container; and analyzing the sample for the analyte of interest. providing a liquid composition (14, 114) comprising a source (12, 112) and a diluent (13, 113); providing a sample preparation system (100, 300) comprising a deformable freestanding liner, and a freestanding container that is more rigid than the deformable liner, and a lid (106, 306); positioning the liquid composition (14, 114) in a reservoir defined by the deformable freestanding liner; coupling the lid (106, 306) to the deformable freestanding liner; positioning the deformable liner within a second reservoir defined by the freestanding container; filtering the liquid composition (14, 114) to form a filtrate (16, 116) comprising the analyte of interest, if present, with the proviso that the filtering step is unnecessary, if the source (12, 112) is completely dissolved in the diluent (13, 113), such that the liquid composition (14, 114) includes a minimal amount of insoluble matter; removing at least a portion of the filtrate (16, 116) or unfiltered liquid composition (14, 114) from the sample preparation system (100, 300) to form a sample by applying pressure to the deformable freestanding liner by hand or by an additional device, via an aperture formed in the base of the free standing container; and analyzing the sample for the analyte of interest.
Method for feeding items of laundry to a laundry treatment device, preferably a mangle, wherein the items of laundry are supplied at a plurality of loading stations arranged next to one another, one item of laundry in each case is transferred by adjacent corner regions of a front edge to spreading clips of a spreading device, the spreading clips being moveable transversely with respect to the feeding direction of the item of laundry, and the front edge of the item of laundry is stretched by the spreading clips and centred with respect to the centre of a feed conveyor, characterized in that the respective item of laundry is transferred to the spreading clips of a pair of spreading clips, that have been brought together, at a lesser distance from the centre of the feed conveyor compared with the outer loading stations, wherein the spreading clips for receiving the respective item of laundry are at a reduced distance from the centre of the feed conveyor compared to outer loading stations, said distance corresponding to at least half of the distance between the two spreading clips of the pair of spreading clips.